Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months - PubMed (original) (raw)
Clinical Trial
. 2005 Jun;365(9475):1957-9.
doi: 10.1016/S0140-6736(05)66552-X.
Miguel Arango, Laura Balica, Rowland Cottingham, Hesham El-Sayed, Barbara Farrell, Janice Fernandes, Tamar Gogichaisvili, Nyoman Golden, Bennie Hartzenberg, Mazhar Husain, Mario Izurieta Ulloa, Zouheir Jerbi, Hussein Khamis, Edward Komolafe, Véronique Laloë, Gabrielle Lomas, Silke Ludwig, Guy Mazairac, Maria de los Angeles Muñoz Sanchéz, Luis Nasi, Fatos Olldashi, Patrick Plunkett, Ian Roberts, Peter Sandercock, Haleema Shakur, Caridad Soler, Reto Stocker, Petr Svoboda, Stefan Trenkler, N K Venkataramana, Jonathan Wasserberg, David Yates, Surakrant Yutthakasemsunt; CRASH trial collaborators
- PMID: 15936423
- DOI: 10.1016/S0140-6736(05)66552-X
Clinical Trial
Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months
Phil Edwards et al. Lancet. 2005 Jun.
Abstract
MRC CRASH is a randomised controlled trial (ISRCTN74459797) of the effect of corticosteroids on death and disability after head injury. We randomly allocated 10,008 adults with head injury and a Glasgow Coma Scale score of 14 or less, within 8 h of injury, to a 48-h infusion of corticosteroid (methylprednisolone) or placebo. Data at 6 months were obtained for 9673 (96.7%) patients. The risk of death was higher in the corticosteroid group than in the placebo group (1248 [25.7%] vs 1075 [22.3%] deaths; relative risk 1.15, 95% CI 1.07-1.24; p=0.0001), as was the risk of death or severe disability (1828 [38.1%] vs 1728 [36.3%] dead or severely disabled; 1.05, 0.99-1.10; p=0.079). There was no evidence that the effect of corticosteroids differed by injury severity or time since injury. These results lend support to our earlier conclusion that corticosteroids should not be used routinely in the treatment of head injury.
Similar articles
- Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial.
Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, Cottingham R, Svoboda P, Brayley N, Mazairac G, Laloë V, Muñoz-Sánchez A, Arango M, Hartzenberg B, Khamis H, Yutthakasemsunt S, Komolafe E, Olldashi F, Yadav Y, Murillo-Cabezas F, Shakur H, Edwards P; CRASH trial collaborators. Roberts I, et al. Lancet. 2004 Oct 9-15;364(9442):1321-8. doi: 10.1016/S0140-6736(04)17188-2. Lancet. 2004. PMID: 15474134 Clinical Trial. - The MRC CRASH Trial: study design, baseline data, and outcome in 1000 randomised patients in the pilot phase.
Edwards P, Farrell B, Lomas G, Mashru R, Ritchie N, Roberts I, Sandercock P, Wasserberg J, Yates D; CRASH Trial Pilot Study Collaborative Group. Edwards P, et al. Emerg Med J. 2002 Nov;19(6):510-4. doi: 10.1136/emj.19.6.510. Emerg Med J. 2002. PMID: 12421773 Free PMC article. Clinical Trial. - Corticosteroid use in head injuries.
Wadia RS. Wadia RS. Natl Med J India. 2005 Jan-Feb;18(1):25. Natl Med J India. 2005. PMID: 15835488 No abstract available. - Are steroids really ineffective for severely head injured patients?
Kamano S. Kamano S. Neurosurg Focus. 2000 Jan 15;8(1):e7. doi: 10.3171/foc.2000.8.1.1640. Neurosurg Focus. 2000. PMID: 16906702 Review. - Corticosteroids for treating Guillain-Barré syndrome.
Hughes RA, van Der Meché FG. Hughes RA, et al. Cochrane Database Syst Rev. 2000;(3):CD001446. doi: 10.1002/14651858.CD001446. Cochrane Database Syst Rev. 2000. PMID: 10908498 Updated. Review.
Cited by
- Steroids in paediatric heart surgery: eminence or evidence-based practice?
Fudulu D, Lightman S, Caputo M, Angelini G. Fudulu D, et al. Indian J Thorac Cardiovasc Surg. 2018 Oct;34(4):483-487. doi: 10.1007/s12055-018-0670-y. Epub 2018 Apr 3. Indian J Thorac Cardiovasc Surg. 2018. PMID: 33060920 Free PMC article. - Glucocorticoid receptor response and glucocorticoid-induced leucine zipper expression in neutrophils of critically ill patients with traumatic and non-traumatic brain injury.
Lotsios NS, Vrettou CS, Poupouzas G, Chalioti A, Keskinidou C, Pratikaki M, Giannopoulou V, Kotanidou A, Vassiliadi DA, Dimopoulou I, Vassiliou AG. Lotsios NS, et al. Front Endocrinol (Lausanne). 2024 Sep 9;15:1414785. doi: 10.3389/fendo.2024.1414785. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39314520 Free PMC article. - Methylprednisolone for the Treatment of Patients with Acute Spinal Cord Injuries: A Propensity Score-Matched Cohort Study from a Canadian Multi-Center Spinal Cord Injury Registry.
Evaniew N, Noonan VK, Fallah N, Kwon BK, Rivers CS, Ahn H, Bailey CS, Christie SD, Fourney DR, Hurlbert RJ, Linassi AG, Fehlings MG, Dvorak MF; RHSCIR Network. Evaniew N, et al. J Neurotrauma. 2015 Nov 1;32(21):1674-83. doi: 10.1089/neu.2015.3963. Epub 2015 Jul 17. J Neurotrauma. 2015. PMID: 26065706 Free PMC article. - Methods to increase response to postal and electronic questionnaires.
Edwards PJ, Roberts I, Clarke MJ, DiGuiseppi C, Woolf B, Perkins C. Edwards PJ, et al. Cochrane Database Syst Rev. 2023 Nov 30;11(11):MR000008. doi: 10.1002/14651858.MR000008.pub5. Cochrane Database Syst Rev. 2023. PMID: 38032037 Free PMC article. Review. - Describing the impact of health research: a Research Impact Framework.
Kuruvilla S, Mays N, Pleasant A, Walt G. Kuruvilla S, et al. BMC Health Serv Res. 2006 Oct 18;6:134. doi: 10.1186/1472-6963-6-134. BMC Health Serv Res. 2006. PMID: 17049092 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical